These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 28228083)

  • 1. Oncolytic Virus: Regulatory Aspects from Quality Control to Clinical Studies.
    Yamaguchi T; Uchida E
    Curr Cancer Drug Targets; 2018; 18(2):202-208. PubMed ID: 28228083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory aspects of oncolytic virus products.
    Yamaguchi T; Uchida E
    Curr Cancer Drug Targets; 2007 Mar; 7(2):203-8. PubMed ID: 17346112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic virus therapy: A new era of cancer treatment at dawn.
    Fukuhara H; Ino Y; Todo T
    Cancer Sci; 2016 Oct; 107(10):1373-1379. PubMed ID: 27486853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting diversity: genetic approaches to creating highly potent and efficacious oncolytic viruses.
    Bauzon M; Hermiston TW
    Curr Opin Mol Ther; 2008 Aug; 10(4):350-5. PubMed ID: 18683099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus combinations and chemotherapy for the treatment of human cancers.
    Kumar S; Gao L; Yeagy B; Reid T
    Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of oncolytic virotherapy: from genetic modification to combination therapy.
    Lan Q; Xia S; Wang Q; Xu W; Huang H; Jiang S; Lu L
    Front Med; 2020 Apr; 14(2):160-184. PubMed ID: 32146606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meeting product development challenges in manufacturing clinical grade oncolytic adenoviruses.
    Working PK; Lin A; Borellini F
    Oncogene; 2005 Nov; 24(52):7792-801. PubMed ID: 16299538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic Virotherapy by HSV.
    Watanabe D; Goshima F
    Adv Exp Med Biol; 2018; 1045():63-84. PubMed ID: 29896663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses.
    Saito K; Shirasawa H; Isegawa N; Shiiba M; Uzawa K; Tanzawa H
    Oral Oncol; 2009 Dec; 45(12):1021-7. PubMed ID: 19833547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization and preclinical design of genetically engineered viruses for human oncolytic therapy.
    Hiss DC; Fielding BC
    Expert Opin Biol Ther; 2012 Nov; 12(11):1427-47. PubMed ID: 22788715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic Immunotherapy.
    Hennessy ML; Bommareddy PK; Boland G; Kaufman HL
    Surg Oncol Clin N Am; 2019 Jul; 28(3):419-430. PubMed ID: 31079797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic Viruses: The Best is Yet to Come.
    Lemay CG; Keller BA; Edge RE; Abei M; Bell JC
    Curr Cancer Drug Targets; 2018; 18(2):109-123. PubMed ID: 28176648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncorine, the World First Oncolytic Virus Medicine and its Update in China.
    Liang M
    Curr Cancer Drug Targets; 2018; 18(2):171-176. PubMed ID: 29189159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers.
    Sinkovics JG; Horvath JC
    Arch Immunol Ther Exp (Warsz); 2008 Dec; 56 Suppl 1():3s-59s. PubMed ID: 19104757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updates to the antitumor mechanism of oncolytic virus.
    Bai Y; Hui P; Du X; Su X
    Thorac Cancer; 2019 May; 10(5):1031-1035. PubMed ID: 30900824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naturally oncolytic viruses.
    Roberts MS; Lorence RM; Groene WS; Bamat MK
    Curr Opin Mol Ther; 2006 Aug; 8(4):314-21. PubMed ID: 16955694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic, immunological, and pharmacological strategies to generate improved oncolytic viruses].
    Pol J; Le Bœuf F; Diallo JS
    Med Sci (Paris); 2013 Feb; 29(2):165-73. PubMed ID: 23452603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances of oncolytic virus in cancer therapy.
    Mondal M; Guo J; He P; Zhou D
    Hum Vaccin Immunother; 2020 Oct; 16(10):2389-2402. PubMed ID: 32078405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oncolytic virus therapy for malignant brain tumors].
    Ino Y; Todo T
    Brain Nerve; 2009 Jul; 61(7):815-22. PubMed ID: 19618859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress of oncolytic viruses in sarcomas.
    Lettieri CK; Hingorani P; Kolb EA
    Expert Rev Anticancer Ther; 2012 Feb; 12(2):229-42. PubMed ID: 22316371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.